顯示所有 12 筆結果
-
Anti-IL-4 [SB240683 (Pascolizumab, humanized 3B9)] (Ab02326-10.0-BT)
-
Anti-IL-4 [SB240683 (Pascolizumab, humanized 3B9)] (Ab02326-10.0)
-
Anti-IL-4 [SB240683 (Pascolizumab, humanized 3B9)] (Ab02326-10.3-BT)
-
Anti-IL-4 [SB240683 (Pascolizumab, humanized 3B9)] (Ab02326-10.3)
-
Anti-IL-4 [SB240683 (Pascolizumab, humanized 3B9)] (Ab02326-23.0-BT)
-
Anti-IL-4 [SB240683 (Pascolizumab, humanized 3B9)] (Ab02326-23.0)
-
Anti-IL-4 [SB240683 (Pascolizumab, humanized 3B9)] (Ab02326-3.0-BT)
-
Anti-IL-4 [SB240683 (Pascolizumab, humanized 3B9)] (Ab02326-3.0)
-
Anti-IL-4 [SB240683 (Pascolizumab, humanized 3B9)] (Ab02326-3.3-BT)
-
Anti-IL-4 [SB240683 (Pascolizumab, humanized 3B9)] (Ab02326-3.3)
-
Anti-PCSK9 [mAb1] (Ab02935-10.0)
-
Anti-PCSK9 [mAb1] (Ab02935-23.0)
